Epsilon M&A Deal Report - Centres de Médecine Nucléaire (Evesio)
Transaction Multiples for the Valuation of Private Companies
Private Group led by MBO&Co / Centres de Médecine Nucléaire (Evesio)
No EMAT :
119413
Announced Date :
17/12/2021
Type :
LBO (Leverage Buy Out)
Deal Value :
Yes
Acquirer :
Private Group led by MBO&Co
Target :
Centres de Médecine Nucléaire (Evesio)
Country :
Seine-Et-Marne
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Medical Diagnostic Laboratory
Business Description :
Founded in 1994 by two physicians shareholders , Centres de Médecine Nucléaire (CMN) - now Evesio - is a private practice dedicated to nuclear medicine France. > Provides advanced diagnostic...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
ns | |
| Current |
|
|
|
|
|
|
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Diagnostic Laboratory » = 55
| Date | Acquirer | Target | Country | Multiples | See details |
| 19/12/2023 | Private Group led by Capza | IMDEV Imagerie Développement | Paris | * | 119278 |
| 15/12/2023 | Carl Zeiss Meditec | Dutch Ophthalmic Research Center International (DORC) | Netherlands | ** | 119224 |
Source: Epsilon Research / EMAT
